Wuxi Apptec, a leading global contract research, development, and manufacturing organisation (CRDMO), is headquartered in Wuxi, China. Founded in 2000, the company has expanded its operational footprint across North America, Europe, and Asia, establishing itself as a key player in the biopharmaceutical industry. Wuxi Apptec offers a comprehensive suite of services, including drug discovery, development, and manufacturing, which are distinguished by their innovative technologies and commitment to quality. The company has achieved significant milestones, such as the establishment of multiple state-of-the-art facilities and a robust portfolio of partnerships with major pharmaceutical firms. Recognised for its market leadership, Wuxi Apptec continues to drive advancements in the life sciences sector, providing essential support to clients in bringing new therapies to market efficiently and effectively.
How does Wuxi Apptec's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Wuxi Apptec's score of 55 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, WuXi AppTec reported total greenhouse gas emissions of approximately 2,287,403,590 kg CO2e. This figure includes Scope 1 emissions of about 66,471,640 kg CO2e, Scope 2 emissions of approximately 531,112,110 kg CO2e, and Scope 3 emissions of around 1,689,819,840 kg CO2e. The combined Scope 1 and 2 emissions totalled about 597,583,750 kg CO2e. For 2023, the company recorded total emissions of about 680,373,980 kg CO2e, with Scope 1 emissions at approximately 68,853,620 kg CO2e, Scope 2 emissions around 467,798,350 kg CO2e, and Scope 3 emissions of about 143,722,000 kg CO2e. WuXi AppTec has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 GHG emissions by 42% by 2030 from a 2024 base year. Additionally, the company targets a 25% reduction in absolute Scope 3 emissions from purchased goods and services and fuel- and energy-related activities within the same timeframe. These targets are aligned with the Science Based Targets initiative (SBTi) and are designed to support the global effort to limit warming to 1.5°C. The company is committed to reducing its GHG emissions intensity by 25% by 2030, starting from 2023. WuXi AppTec's climate initiatives reflect its dedication to sustainability within the pharmaceuticals, biotechnology, and life sciences sector, based in China.
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 6,643,770 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 144,938,320 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Wuxi Apptec is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
